Dissection of the Process of Brain Metastasis Reveals Targets and Mechanisms for Molecular-based Intervention

Ulrich H Weidle1, Fabian Birzele2, Gwendlyn Kollmorgen1

  • 1Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany.

Insights

Brain metastases, common in cancer patients, have poor prognoses. This review details brain metastasis mechanisms, therapeutic targets, and highlights druggable mutations in metastases.

Area of Science:

  • Oncology
  • Neuroscience
  • Cancer Biology

Background:

  • Brain metastases are more common than primary brain tumors, with limited treatment options and poor patient prognosis.
  • Understanding the mechanisms of brain metastasis is crucial for developing effective therapies.

Purpose of the Study:

  • To review the process of brain metastasis, focusing on breast cancer, lung cancer, and melanoma.
  • To identify therapeutic targets for preventing and treating brain metastases.
  • To discuss the implications of genetic mutations found in brain metastases.

Main Methods:

  • Review of existing literature on brain metastasis mechanisms.
  • Analysis of tumor cell interactions with the brain microenvironment.
  • Identification of molecular targets for therapeutic intervention.

Main Results:

  • Disseminated tumor cells penetrate the blood-brain barrier (BBB), establish niches, and colonize the brain.
  • Angiogenesis, microglia/astrocyte interactions, and cancer cell neuromimicry play key roles in brain colonization.
  • Druggable mutations are present in brain metastases, sometimes distinct from primary tumors.

Conclusions:

  • Targeting specific mechanisms of brain metastasis, such as BBB penetration and niche formation, offers therapeutic potential.
  • Exploiting unique mutations in brain metastases may lead to personalized treatment strategies.
  • Further research into the biology of brain metastases is essential for improving patient outcomes.